Renal Compensation for Impaired Hepatic Glucose Release During Hypoglycemia in Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
During liver transplantation and after both meal ingestion and prolonged fasting, renal glucose release (RGR) increases while hepatic glucose release (HGR) decreases. These and other observations have led to the concept of hepatorenal reciprocity. According to this concept, reciprocal changes in hepatic and renal glucose release may occur to minimize deviations from normal glucose homeostasis. We further assessed this concept by testing the hypothesis that during counterregulation of hypoglycemia in patients with type 2 diabetes, who would be expected to have reduced HGR, RGR would be increased. Accordingly, we performed hypoglycemic hyperinsulinemic clamp experiments (∼3.1 mmol/l) in 12 type 2 diabetic and in 10 age-weight-matched nondiabetic volunteers and measured total endogenous glucose release (TEGR) and RGR using a combined isotopic net balance approach. HGR was calculated as the difference between TEGR and RGR since only these organs are capable of releasing glucose. We found that during comparable hypoglycemia and hyperinsulinemia, TEGR was reduced in type 2 diabetes (6.6 ± 0.6 vs. 10.2 ± 1.1 μmol · kg−1 · min−1 in nondiabetic volunteers, P = 0.01) due to reduced HGR (3.9 ± 0.5 vs. 8.6 ± 1.0 μmol · kg−1 · min−1 in nondiabetic volunteers, P = 0.0015). In contrast, RGR was increased approximately twofold in type 2 diabetes (3.3 ± 0.5 vs. 1.6 ± 0.3 μmol · kg−1 · min−1 in nondiabetic volunteers, P = 0.015). Plasma epinephrine, lactate, and free fatty acid concentrations, which would promote RGR, were also greater in type 2 diabetes (all P < 0.01). Our results provide further support for hepatorenal reciprocity and may explain at least in part the relatively low occurrence of severe hypoglycemia in type 2 diabetes compared with type 1 diabetes where both HGR and RGR counterregulatory responses are reduced.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus
Stumvoll, M., Nurjhan, N., Perriello, G., Dailey, G., & Gerich, J. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508313330903 · Cited by 1,148 · cited 2×
“Metformin has been shown to reduce hepatic gluconeogenesis in vitro (51) and the incorporation of lactate into glucose in humans (34).”
BackgroundSelf-citationMagnusson, I., Rothman, D. L., Katz, L. D., Shulman, R. G., & Shulman, G. I. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115997 · Cited by 757 · cited 3×
“These patients have reduced hepatic glycogen stores (17) and, like those with type 1 diabetes, often have impaired glucagon responses to hypoglycemia (18–21), particularly as they approach the insulin-deficient end of the spectrum of type 2 diabetes (22).”
BackgroundMethodRole of Glucagon, Catecholamines, and Growth Hormone in Human Glucose Counterregulation
Rizza, R. A., Cryer, P. E., & Gerich, J. E. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109464 · Cited by 421 · cited 1×
“These hormones act primarily by increasing glucose release and, to a lesser extent, by limiting glucose utilization (4).”
BackgroundSelf-citationHypoglycemia-associated autonomic failure in advanced type 2 diabetes.
Segel, S. A., Paramore, D. S., & Cryer, P. E. (2002) · Diabetes · doi:10.2337/diabetes.51.3.724 · Cited by 337 · cited 2×
“These patients have reduced hepatic glycogen stores (17) and, like those with type 1 diabetes, often have impaired glucagon responses to hypoglycemia (18–21), particularly as they approach the insulin-deficient end of the spectrum of type 2 diabetes (22).”
BackgroundSelf-citationHypoglycemia in Hospitalized Patients
Fischer, K. F., Lees, J. A., & Newman, J. H. (1986) · New England Journal of Medicine · doi:10.1056/nejm198611133152002 · Cited by 309 · cited 1×
“Another clinical implication of our findings relates to the propensity of type 2 diabetic patients for severe hypoglycemia when they develop end-stage renal disease (8,46,47).”
BackgroundRole of human liver, kidney, and skeletal muscle in postprandial glucose homeostasis
Meyer, C., Dostou, J. M., Welle, S. L., & Gerich, J. E. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00032.2001 · Cited by 269
Self-citationGlucose counterregulation: prevention and correction of hypoglycemia in humans
Cryer, P. E. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.264.2.e149 · Cited by 198 · cited 2×
“The key element in this defense is an increase in secretion of counterregulatory hormones (glucagon, epinephrine, growth hormone, and cortisol) when plasma glucose levels decrease below a certain threshold (2,3).”
BackgroundSelf-citationCounterregulatory hormone responses to hypoglycemia in the elderly patient with diabetes
Meneilly, G. S., Cheung, E., & Tuokko, H. (1994) · Diabetes · doi:10.2337/diab.43.3.403 · Cited by 167
Counterregulatory hormone responses to hypoglycemia in the elderly patient with diabetes
Meneilly, G. S., Cheung, E., & Tuokko, H. (1994) · Diabetes · doi:10.2337/diabetes.43.3.403 · Cited by 167
Bolli, G. B., Tsalikian, E., Haymond, M. W., Cryer, P. E., & Gerich, J. E. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111359 · Cited by 108 · cited 3×
“Although type 2 diabetic patients have been reported to have reduced hepatic glucose release during counterregulation of hypoglycemia (19), severe hypoglycemia is relatively uncommon in them compared with those with type 1 diabetes (16).”
BackgroundMethodResultSelf-citation
Cited by
Hypoglycemia in Type 2 Diabetes
Zammitt, N. N., & Frier, B. M. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2948 · Cited by 435
Dunning, B. E., & Gerich, J. E. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0026 · Cited by 369
Self-citationLactate kinetics in human tissues at rest and during exercise
van Hall, G. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02122.x · Cited by 346
“Moreover, a small but consistent unidirectional lactate release is found accounting for 4–5% of systemic lactate production (Meyer et al. 2002, Woerle et al. 2003).”
BackgroundPugliese, G., Penno, G., Natali, A., Barutta, F., Di Paolo, S., Reboldi, G., Gesualdo, L., & De Nicola, L. (2019) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.07.017 · Cited by 156
Plomgaard, P., Hansen, J. S., Ingerslev, B., Clemmesen, J. O., Secher, N. H., van Hall, G., Fritsche, A., Weigert, C., Lehmann, R., Häring, H., et al. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13615 · Cited by 16
Metadata
- Authors
- Woerle, H. J., Meyer, C., Popa, E. M., Cryer, P. E., & Gerich, J. E.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2003-06-01
- Volume
- 52
- Issue
- 6
- Pages
- 1386-1392
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2086077582
- Cited by
- 52
- References
- 11
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Renal Compensation for Impaired Hepatic Glucose Release During Hypoglycemia in Type 2 Diabetes. https://app.cochat.ai/papers/10.2337/diabetes.52.6.1386
- The paper
- Woerle, H. J., Meyer, C., Popa, E. M., Cryer, P. E., & Gerich, J. E. (2003). Renal Compensation for Impaired Hepatic Glucose Release During Hypoglycemia in Type 2 Diabetes. Diabetes. https://doi.org/10.2337/diabetes.52.6.1386
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.